Dengue Vaccine: Huge Public Health Scandal Erupts in Phillipines
Philippines halts programme for 'dangerous' dengue fever vaccine given to 730,000 children
Vaccine used in £51.5m immunisation drive can cause severe cases of potentially fatal infection, admits manufacturer
http://www.independent.co.uk/news/world/asia/dengvaxia-philippines-halts-dengue-fever-immunisation-programme-after-730000-children-given-a8086396.html
Sanofi confirms suspected safety issue with dengue vaccine
http://www.pmlive.com/pharma_news/sanofi_confirms_suspected_safety_issue_with_dengue_vaccine_1212944?SQ_DESIGN_NAME=2&
'Biggest public health scam': Expert wants legal action over risky vaccine program
ABS-CBN News
Philippines dengue vaccine: Investigation launched into Sanofi drug after learning it may worsen disease
Non-governmental organisation receives information that three children who were vaccinated in 2016 died, but drug maker says no deaths been reported because of programme
http://www.independent.co.uk/news/world/asia/philippines-dengue-vaccine-latest-updates-sanofi-children-france-drug-company-manila-a8090366.html
VACC to seek probe into alleged anomalous purchase of dengue vaccines
by UNTV News | Posted on Monday, December 4th, 2017
http://www.independent.co.uk/news/world/asia/philippines-dengue-vaccine-latest-updates-sanofi-children-france-drug-company-manila-a8090366.html
How red tape over a dengue vaccine avoided a health crisis
The Philippines launches probe after Sanofi reveals WHO-approved dengvaxia aggravates symptoms in some cases
Abhineet Kumar & Veena Mani | Mumbai/Delhi Last Updated at December 5, 2017 00:59 ISThttp://www.business-standard.com/article/current-affairs/how-red-tape-saved-india-from-a-dengue-vaccine-health-crisis-117120401172_1.html
WHO reviewing data on Sanofi dengue vaccine, urges limited use; awaits approval in India
The World Health Organization (WHO) said on Monday it hoped to conduct a “full review” by year-end of data on Sanofi’s dengue vaccine Dengvaxia
http://www.hindustantimes.com/health/who-reviewing-data-on-sanofi-dengue-vaccine-urges-limited-use-awaits-approval-in-india/story-BlBx4rd0oyYPE6yWjmKsFM.html
Sanofi’s belated admission of a lethal Dengvaxia threat came long after multiple high-profile warnings
https://endpts.com/sanofis-belated-admission-of-a-lethal-dengvaxia-threat-came-after-multiple-high-profile-warnings/
Post a Comment